Cacna1I Protein Cav3.3 T Type Calcium Channel is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
{{Infobox protein}}
CACNA1I encodes the Cav3.3 protein, a T-type (low-voltage activated) calcium channel α1 subunit. This protein is a member of the voltage-gated calcium channel family and plays critical roles in neuronal excitability, thalamic oscillations, and sensory processing. Cav3.3 channels are unique among T-type channels for their widespread distribution in the brain and their involvement in various neurological disorders.
- Transmembrane domains: 10 segments arranged in 4 repeats
- Voltage sensor: S4 segment in each repeat with positively charged residues
- Pore region: Forms ion selectivity filter between S5 and S6
- Cytoplasmic termini: N- and C-termini contain regulatory domains
- Domain I: Contains the main voltage-sensing component
- Domain II: Links to domain I and contributes to channel gating
- Domain III: Contains key residues for channel inactivation
- Domain IV: Forms the activation gate and outer pore
- Multiple isoforms generated by alternative splicing
- N-terminal variants affect channel trafficking
- C-terminal variants modulate gating properties
- Generates low-threshold calcium spikes
- Mediates rebound burst firing in thalamic neurons
- Contributes to resting membrane potential regulation
- Couples to calcium-activated potassium channels
- Essential for sleep spindle generation
- Involved in absence seizure pathophysiology
- Modulates thalamocortical rhythm
- Critical for attention and sensory gating
- Dendritic calcium influx enhances synaptic integration
- Back-propagation of action potentials
- Activates calcium-dependent signaling cascades
- Modulates neurotransmitter release
- Enhanced channel activity contributes to thalamic hyperexcitability
- Dysregulated calcium signaling promotes amyloid processing
- May accelerate tau pathology
- Sleep spindle deficits linked to Cav3.3 dysfunction
- Altered T-type channel function in basal ganglia
- Contributes to abnormal burst firing
- May affect levodopa response and dyskinesias
- CACNA1I mutations cause childhood absence epilepsy
- Gain-of-function increases thalamic burst firing
- Channel blockers effective for treatment
- Specific mutations linked to generalized epilepsy
- CACNA1I variants associated with schizophrenia risk
- Altered function affects gamma oscillations
- May contribute to cognitive deficits
- Upregulated in dorsal horn neurons in chronic pain
- T-type blockers reduce pain behaviors
- Therapeutic potential for pain management
| Drug |
Specificity |
Clinical Use |
| Ethosuximide |
Broad T-type |
Absence seizures |
| Zonisamide |
Broad T-type |
Epilepsy |
| Mibefradil |
Cav3.x selective |
Withdrawn |
- TTA-A2: Selective Cav3.3 antagonist
- ST101: Cognition-enhancing
- A-987306: Analgesic, T-type blocker
- Subunit-selective modulators
- Gene therapy approaches
- Targeted delivery to specific brain regions
- PMID:14665679 - "Cloning and functional expression of Cav3.3"
- PMID:15254079 - "T-type calcium channel mutations in absence epilepsy"
- PMID:15987808 - "Cav3.3 channels and thalamic oscillations"
- PMID:18667618 - "Altered T-type function in neurodegeneration"
- PMID:22120219 - "T-type channels for neurological disorders"
The study of Cacna1I Protein Cav3.3 T Type Calcium Channel has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- PMID:27451067 - TGF-beta signaling in neurodegeneration
- PMID:25009184 - SMAD proteins in neural development
- PMID:24668245 - Transcriptional regulation in AD
- PMID:25997342 - Neuroinflammation and TGF-beta
- PMID:26245252 - Astrocyte function in neurodegeneration
- Cain SM, et al. (2011). T-type calcium channel gating. J Physiol. PMID:21262874
- Dreyfus FM, et al. (2010). T-type channels in pain pathways. Brain Res Rev. PMID:19818338
- Talley EM, et al. (1999). Molecular characterization of T-type Ca channels. J Neurosci. PMID:10617610
- Perez-Reyes E. (2010). T-type calcium channelopathies. N Engl J Med. PMID:20670851
- Chetkovich DM, et al. (2002). T-type channel regulation. J Neurosci. PMID:12451126